The original Right to Try movement aimed to give terminally ill patients greater access to investigational treatments. The movement succeeded in getting a federal law enacted in 2018, but due in part to concerns around liability, it has not been used as much as advocates had hoped. A new state-based movement, called Expanded Right to Try, seeks to remedy that.
Continue reading...
Health Savings Accounts (HSAs) and Flexible Spending Accounts (FSAs) are often lauded as tools that empower consumers to take control of their healthcare spending. They encourage saving, and are seen as market-driven solutions. But we should remember that HSAs and FSAs are not really triumphs of freedom; they are symbols of how convoluted and overregulated our healthcare system is.
Continue reading...
Private equity involvement in healthcare has grown rapidly in the past twenty years, with annual investments reaching an estimated $505 billion in 2023. High-profile failures, however, have fueled criticism about PE practices. This working paper takes a critical look at the most common complaints and evaluates whether government intervention is warranted.
Continue reading...
Reform of the graduate medical education funding model is badly needed. In the short term, expansion of residency slots could alleviate the artificial shortage of residency slots brought about by current government policy. In the long term, policymakers should more fundamentally rethink the need for federal funding in graduate medical education.
Continue reading...